Sarah Aiosa is President, Latin America for Merck & Co., a Fortune 500 Multinational Pharmaceutical Company, where she is responsible for managing a ~$2B+ P&L for the Human Health Portfolio across the region, encompassing 5,000 employees in more than 30 countries. Previously, Sarah was CEO/Managing Director of MSD Sweden where she managed a ~$200M P&L and the company was certified among the Best Places to Work under her leadership. In 2023, she was recognized as one of the 50 Most Powerful Latinas by ALPFA, the Association of Latino Professionals for America. She is an Executive Member of the Latino Corporate Directors Association (LCDA) and obtained her Board Ready Certification for Excellence in Board Governance by LCDA, KPMG and University of California Law San Francisco in 2023.